ENDPOINTS

Novartis touts Zolgensma data in older children

Novartis released two Phase 3 datasets on Wednesday that show a new version of its gene therapy Zolgensma led to motor function improvements in patients with spinal muscular atrophy. The company hopes the data will ...

Mar 19, 2025 - 20:44
 0
Novartis touts Zolgensma data in older children
Novartis released two Phase 3 datasets on Wednesday that show a new version of its gene therapy Zolgensma led to motor function improvements in patients with spinal muscular atrophy. The company hopes the data will ...
Read More

Tags:

Previous Article

These scientists are building a cat database to understand why they act like that

Next Article

Jury Finds Greenpeace Liable for Hundreds of Millions in Damages

Related Posts

Corrected: Merck opens billion-dollar US facility to make Gardasil

Corrected: Merck opens billion-dollar US facility to ma...

Mar 11, 2025  0

Merck KGaA confirms interest in acquiring cancer biotech SpringWorks

Merck KGaA confirms interest in acquiring cancer biotec...

Feb 10, 2025  0

Exclusive: RNA delivery startup strikes partnerships with J&J, Daiichi Sankyo

Exclusive: RNA delivery startup strikes partnerships wi...

Mar 10, 2025  0